Research Article
Evaluation of Thyroid Function in Patients Hospitalized for Acute Heart Failure
Table 1
Clinical characteristics of the patients (n = 235).
| Age (years), mean (SD) | 77.4 (10.4) | Female sex | 58.7 | BMI, kg/m2, mean (SD) | 27.1 (5.3) | Length of stay in hospital, median (IQR) | 8 (5–12) |
| Comorbidities | History of heart failure | 92.8 | Classification | LVEF < 40% | 39.8 | LVEF 40-49% | 10.9 | LVEF ≥ 50% | 49.3 |
| NYHA class prior to hospitalization | I | 9.0 | II | 52.6 | III | 35.9 | IV | 2.6 | Coronary artery disease | 45.7 | Valvular disease | 43.8 | Atrial fibrillation | 48.7 | Hypertension | 77.9 | Diabetes mellitus | 57.0 | Dyslipidaemia | 82.1 | Chronic kidney disease | 45.1 | COPD | 22.6 | Current smoker | 10.0 |
| Vital signs on admission | Heart rate (bpm), mean (SD) | 90.0 (24.8) | Blood pressure (mmHg), mean (SD) | Systolic | 131.8 (29.2) | Diastolic | 73.5 (18.3) |
| Inpatient echocardiographic measures | LVEF, %, mean (SD) | 36.0 (16.4) | PASP, mmHg, mean (SD) | 47.3 (17.6) |
| Laboratory values on admission | TSH, μIU/mL, median (IQR) | 1.12 (0.59–2.11) | Free T4, ng/dL, mean (SD) | 1.14 (0.27) | eGFR, mL/min/1.73 m2, mean (SD) | 47.2 (30.9–67.5) | BNP, pg/mL, median (IQR) | 920.2 (477.3–1639.0) |
|
|
Values are presented as percentages, except when indicated. SD: standard deviation; BMI: body mass index; IQR: interquartile range; LVEF: left ventricle ejection fraction; NYHA: New York Heart Association; COPD: chronic obstructive pulmonary disease; PASP: pulmonary arterial systolic pressure; TSH: thyroid-stimulating hormone; T4: thyroxine; eGFR: estimated glomerular filtration rate; BNP: B-type natriuretic peptide.
|